Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Healthtrust
Merck
Accenture
Farmers Insurance
Mallinckrodt
Medtronic
McKesson
UBS

Generated: May 24, 2018

DrugPatentWatch Database Preview

NUTROPIN Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Nutropin, and when can generic versions of Nutropin launch?

Nutropin is a drug marketed by Genentech and is included in three NDAs.

The generic ingredient in NUTROPIN is somatropin recombinant. There are four drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the somatropin recombinant profile page.
Summary for NUTROPIN
US Patents:0
Applicants:1
NDAs:3
Clinical Trials: 13
Formulation / Manufacturing:see details
DailyMed Link:NUTROPIN at DailyMed
Drug patent expirations by year for NUTROPIN

US Patents and Regulatory Information for NUTROPIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Genentech NUTROPIN somatropin recombinant INJECTABLE;INJECTION 020168-001 Nov 17, 1993 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Genentech NUTROPIN AQ PEN somatropin recombinant INJECTABLE;INJECTION 020522-002 Apr 22, 2002 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Genentech NUTROPIN AQ NUSPIN somatropin recombinant INJECTABLE;INJECTION 020522-003 Jan 3, 2008 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Genentech NUTROPIN AQ PEN somatropin recombinant INJECTABLE;INJECTION 020522-006 Jan 3, 2008 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for NUTROPIN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Genentech NUTROPIN somatropin recombinant INJECTABLE;INJECTION 020168-001 Nov 17, 1993 ➤ Sign Up ➤ Sign Up
Genentech NUTROPIN somatropin recombinant INJECTABLE;INJECTION 020168-002 Nov 17, 1993 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Harvard Business School
Julphar
Johnson and Johnson
Queensland Health
Farmers Insurance
McKinsey
QuintilesIMS
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.